Notice of Proposed Sale · 144
Rocket Pharmaceuticals, Inc.
RCKTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- ROCKET PHARMACEUTICALS, INC.
- Issuer CIK
- 0001281895
- SEC file number
- 001-36829
- Phone
- 646-440-9100
- Person for whose account securities are to be sold
- Shah Gaurav
- Relationships to issuer
- Officer · Director
- Street
- 350 FIFTH AVENUE
- Street (continued)
- SUITE 7530
- City
- NEW YORK
- State / country code
- NY
- Postal code
- 10118
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 2,293 | 7,753.55 | 109,774,597 | 08/18/2026 | NASDAQ | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/14/2026 | Restricted Stock Vesting | Issuer | 2,293 | N | 08/14/2026 | Compensation |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Gaurav Shah | Common | 05/19/2026 | 2,409 | 7,261.69 |
| Gaurav Shah | Common | 05/21/2026 | 55,684 | 171,818.55 |
| Gaurav Shah | Common | 08/13/2026 | 2,837 | 9,592.18 |
Seller — prior-sale row 1, entry 1
- Name
- Gaurav Shah
- Street
- 9 Cedarbrook Drive
- City
- Cranbury
- State / country code
- NJ
- Postal code
- 08512
Seller — prior-sale row 2, entry 1
- Name
- Gaurav Shah
- Street
- 9 Cedarbrook Drive,
- City
- Cranbury
- State / country code
- NJ
- Postal code
- 08512
Seller — prior-sale row 3, entry 1
- Name
- Gaurav Shah
- Street
- 9 Cedarbrook Drive
- City
- Cranbury
- State / country code
- NJ
- Postal code
- 08512
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Notice signature
- Notice date
- 08/18/2026
- Signed
- /s/ Louis Kurnick, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gaurav Shah
Company context
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a fully integrated commercial-stage biotechnology company developing genetic medicines for rare and life-threatening diseases, with a strategic focus on inherited cardiovascular disorders and additional programs in hematology and immunology. Rocket's cardiovascular portfolio includes three clinical-stage gene therapy programs targeting hypertrophic, arrhythmogenic, and dilated cardiomyopathies, together representing one of the broadest pipelines focused on inherited heart disease. The Company’s integrated platform combines proprietary adeno-associated virus (AAV) manufacturing capabilities and extensive clinical experience in cardiac gene therapy.
Current securities
Historical securities (1)
Recent company filings
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Regulation FD DisclosureOct 6, 2026
- Regulation FD DisclosureSep 15, 2026
- 144 filingSep 11, 2026
- 25-NSE - filed by Nasdaq Stock Market LLC regarding ROCKET PHARMACEUTICALS, INC.Sep 2, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 27, 2026